Behandling med Naglazyme bør overvåges af en læge med erfaring med behandling af patienter med MPS VI eller andre arvelige metaboliske sygdomme.
Naglazyme treatment should be supervised by a physician experienced in the management of patients with MPS VI or other inherited metabolic diseases.